Fig. 2From: Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational studyMean scores for depressive symptoms (MADRS-S) and sleep quality (Total PSQI) from baseline to post-treatment. Depressive symptoms were lower 12Â weeks post-treatment. Total PSQI did not significantly change during DAA treatment. Abbreviations: MADRS-S, self-rating version of the Montgomery Ă sberg Depression Rating Scale; PSQI, Pittsburgh Sleep Quality Index; 4WTx, 4Â weeks of treatment; 8WTx, 8Â weeks of treatment; EOT, end of treatment; 12WpostTx, twelve weeks post-treatmentBack to article page